Related Experiment Video

Updated: Jun 20, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

TGF-beta in dopamine neuron development, maintenance and neuroprotection

Eleni Roussa1, Oliver von Bohlen und Halbach, Kerstin Krieglstein

  • 1Institute for Anatomy and Cell Biology, Department of Molecular Embryology, University of Freiburg, Freiburg, Germany.

Advances in Experimental Medicine and Biology
|September 8, 2009
PubMed

Insights

Transforming growth factor betas (TGF-betas) regulate nervous system development and function, including the survival and neuroprotection of dopaminergic neurons. This review focuses on TGF-beta and GDNF

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • Transforming growth factor betas (TGF-betas) are critical cytokines with diverse roles in the nervous system.
  • These roles include regulating neuronal proliferation, migration, differentiation, survival, and death.

Purpose of the Study:

  • To review the literature on the effects of TGF-beta on mesencephalic dopaminergic (DAergic) neurons.
  • To explore the mechanisms underlying TGF-beta's neuroprotective effects in Parkinson's disease models.
  • To examine the interplay between TGF-beta and glial cell-line-derived neurotrophic factor (GDNF).

Main Methods:

  • Literature review of experimental in vitro and in vivo studies.
  • Analysis of studies focusing on TGF-beta and GDNF signaling pathways.
  • Examination of animal models of Parkinsonism.

Main Results:

  • TGF-beta influences the induction and specification of the dopaminergic phenotype.
  • TGF-beta promotes the survival of DAergic neurons.
  • TGF-beta exhibits neuroprotective effects in animal models of Parkinsonism.
  • Synergistic interactions between TGF-beta superfamily members have been identified.

Conclusions:

  • TGF-beta plays a crucial role in the development, survival, and neuroprotection of DAergic neurons.
  • Understanding TGF-beta and GDNF mechanisms offers potential therapeutic strategies for neurodegenerative diseases like Parkinson's.
  • Further research into TGF-beta superfamily interactions is warranted.

More Related Videos

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons10:53

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons

Published on: September 15, 2014

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...